AbbVie Buys Into Obesity With Gubra Deal, While Novo Partners With Gensaic

Two Deals Across Weight Loss, Cardiometabolic Diseases

 
• By Mandy Jackson
  
Big pharma continues buying into the obesity space (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Scrip